Cure Pharmaceutical Corporation – Trademark Portfolio
Entity Type: 03
Cure Pharmaceutical Corporation holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include C, CUREFILM, CURE PHARMACEUTICAL, C CURE PHARMACEUTICAL, and DELIVERING THE PROMISE OF HEALTHIER LIVES. The owner is based in Oxnard, CA.
1620 Beacon Place
Oxnard, CA 93033
Showing of trademarks Trademarks
Trademark Classifications
Cure Pharmaceutical Corporation's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Cure Pharmaceutical Corporation have?
Cure Pharmaceutical Corporation has 5 U.S. trademarks filed with the USPTO. Of these, 5 registered.
What trademark classes does Cure Pharmaceutical Corporation file in?
Cure Pharmaceutical Corporation files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Cure Pharmaceutical Corporation's most well-known trademarks?
Cure Pharmaceutical Corporation's registered trademark portfolio includes well-known marks such as C, CUREFILM, CURE PHARMACEUTICAL, C CURE PHARMACEUTICAL, and DELIVERING THE PROMISE OF HEALTHIER LIVES. These are among 5 currently registered trademarks in the portfolio.
What is Cure Pharmaceutical Corporation's trademark registration success rate?
Cure Pharmaceutical Corporation has a 100% trademark registration rate, with 5 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.